We have previously demonstrated that deletion or mutation of the tumour suppressor gene Trp53 alongside activating mutation of Kras can give rise to aggressive, late-stage adenocarcinoma development in the intestine32. The gene discussed is KRAS; the disease is adenocarcinoma.